4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kyntra Bio, Inc. (KYNB) operates in the Biotechnology industry and is headquartered in San Francisco, United States with about 34 employees. Its market capitalization is roughly $29 million. In the fiscal year ended 2025-12-31, KYNB reported $6M in revenue and $184M in net income.
Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers.
Interactive charts & full statements → Open the KYNB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $6M | $30M | $47M | $141M | — |
| Gross Profit | $6M | $14M | $43M | $120M | — |
| Operating Income (EBIT) | ($45M) | ($131M) | ($310M) | ($301M) | — |
| Net Income | $184M | ($48M) | ($284M) | ($294M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $4M | $1M | $1M | $1M | $3M |
| Gross Profit | ($0M) | $1M | $1M | $1M | $2M |
| Operating Income (EBIT) | ($14M) | ($14M) | ($5M) | ($12M) | ($15M) |
| Net Income | ($15M) | ($14M) | $201M | ($8M) | $5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $120M | $214M | $424M | $610M | — |
| Total Liabilities | $115M | $398M | $586M | $612M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KYNB viewer.
About TickerBase · Data methodology & sources